Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 3, 2012, Pages 655-660

  Reddy, Krishna ^a   Damek, Denise ^a   Gaspar, Laurie E ^a   Ney, Douglas ^a   Waziri, Allen ^a   Lillehei, Kevin ^a   Stuhr, Kelly ^a   Kavanagh, Brian D ^a   Chen, Changhu ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Chemoradiation therapy; Glioblastoma; High grade glioma; Hypofractionation; Radiation therapy

Indexed keywords

ADVERSE EVENTS; BONE MARROW; BRAIN MRI; CHEMORADIATION; COMMON TERMINOLOGY CRITERIA; GLIOBLASTOMAS; HIGH-GRADE GLIOMAS; HYPOFRACTIONATION; INTENSITY-MODULATED RADIOTHERAPY; NEWLY DIAGNOSED GLIOBLASTOMA; NONHEMATOLOGIC TOXICITY; OVERALL SURVIVAL; PERFORMANCE STATUS; PHASE II; RESIDUAL TUMORS; TEMOZOLOMIDE; TOTAL DOSE;

MAGNETIC RESONANCE IMAGING; RADIOTHERAPY; SURGERY; TOXICITY; TUMORS;

PHYSICAL THERAPY;

DEXAMETHASONE; TEMOZOLOMIDE;

ACUTE TOXICITY; ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CHRONIC TOXICITY; CLINICAL ARTICLE; COGNITIVE DEFECT; CONFUSION; DRUG DOSE REDUCTION; DRUG INDUCED HEADACHE; FATIGUE; FEMALE; FOCAL EPILEPSY; FOLLOW UP; GLIOBLASTOMA; HEADACHE; HUMAN; INSOMNIA; INTENSITY MODULATED RADIATION THERAPY; KARNOFSKY PERFORMANCE STATUS; LEUKOPENIA; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION NECROSIS; REOPERATION; STEROID THERAPY; THROMBOCYTOPENIA; TUMOR BIOPSY; TUMOR RECURRENCE; WEAKNESS;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CHEMORADIOTHERAPY; CHEMOTHERAPY, ADJUVANT; DACARBAZINE; DEXAMETHASONE; DOSE FRACTIONATION; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; REOPERATION; TUMOR BURDEN;

EID: 84866740043     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.01.035     Document Type: Article

References (19)

1. R. Stupp, M.E. Hegi, and W.P. Mason Effects of radiotherapy with concomitant and adjuvant TMZ versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-Year analysis of the EORTC-NCIC trial Lancet Oncol 10 2009 459 466
2. F.H. Hochberg, and A. Pruitt Assumptions in the radiotherapy of glioblastoma Neurology 30 1980 907 911
3. C. Chen, D. Damek, and L.E. Gaspar Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme Int J Radiat Oncol Biol Phys 81 2011 1066 1074
4. K. Nakagawa, Y. Aoki, and T. Fujimaki High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme Int J Radiat Oncol Biol Phys 40 1998 1141 1149
5. J.L. Chan, S.W. Lee, and B.A. Fraass Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy J Clin Oncol 20 2002 1635 1642
6. W. Roa, P.M. Brasher, and G. Bauman Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: A prospective randomized clinical trial J Clin Oncol 22 2004 1583 1588
7. G. Minniti, V. De Sanctis, and R. Muni Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma J Neurooncol 91 2009 95 100
8. K. Sultanem, H. Patrocinio, and C. Lambert The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: Preliminary results of a prospective trial Int J Radiat Oncol Biol Phys 58 2004 247 252
9. N.S. Floyd, S.Y. Woo, and B.S. Teh Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme Int J Radiat Oncol Biol Phys 58 2004 721 726
10. T. Iuchi, K. Hatano, and Y. Narita Hypofractionated high-dose irradiation for the treatment of malignant astrocytomas using simultaneous integrated boost technique by IMRT Int J Radiat Oncol Biol Phys 64 2006 1317 1324
11. J.D. Ruben, M. Dally, and M. Bailey Cerebral radiation necrosis: Incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy Int J Radiat Oncol Biol Phys 65 2006 499 508
12. K.E. Rusthoven, C. Olsen, and W. Franklin Favorable prognosis in patients with high-grade glioma with radiation necrosis: The University of Colorado reoperation series Int J Radiat Oncol Biol Phys 81 2011 211 217
13. M.M. Fitzek, A.F. Thornton, and J.D. Rabinov Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: Results of a phase II prospective trial J Neurosurg 91 1999 251 260
14. C. Peca, R. Pacelli, and A. Elefante Early clinical and neuroradiological worsening after radiotherapy and concomitant temozolomide in patients with glioblastoma: Tumour progression or radionecrosis? Clin Neurol Neurosurg 111 2009 331 334
15. I. Yang, and M.K. Aghi New advances that enable identification of glioblastoma recurrence Nat Rev Clin Oncol 6 2009 648 657
16. R. Torcuator, R. Zuniga, and Y.S. Mohan Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis J Neurooncol 94 2009 63 68
17. J. Gonzalez, A.J. Kumar, and C.A. Conrad Effect of bevacizumab on radiation necrosis of the brain Int J Radiat Oncol Biol Phys 67 2007 323 326
18. V.A. Levin, L. Bidaut, and P. Hou Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system Int J Radiat Oncol Biol Phys 79 2011 1487 1495
19. J.J. Vredenburgh, A. Desjardins, and J.E. Herndon II Bevacizumab plus irinotecan in recurrent glioblastoma multiforme J Clin Oncol 25 2007 4722 4729